Developing timely insights into comparative effectiveness research with a text-mining pipeline.

Comparative effectiveness research (CER) provides evidence for the relative effectiveness and risks of different treatment options and informs decisions made by healthcare providers, payers, and pharmaceutical companies. CER data come from retrospective analyses as well as prospective clinical trials. Here, we describe the development of a text-mining pipeline based on natural language processing (NLP) that extracts key information from three different trial data sources: NIH ClinicalTrials.gov, WHO International Clinical Trials Registry Platform (ICTRP), and Citeline Trialtrove. The pipeline leverages tailored terminologies to produce an integrated and structured output, capturing any trials in which pharmaceutical products of interest are compared with another therapy. The timely information alerts generated by this system provide the earliest and most complete picture of emerging clinical research.

[1]  David Milward,et al.  Ontology-Based Interactive Information Extraction From Scientific Abstracts , 2005, Comparative and functional genomics.

[2]  D. Ghersi,et al.  Pharmacokinetic research in children: an analysis of registered records of clinical trials , 2011, BMJ Open.

[3]  Adrian Thomas,et al.  Health technology assessment and comparative effectiveness research: a pharmaceutical industry perspective , 2013, Expert review of pharmacoeconomics & outcomes research.

[4]  D. Kent,et al.  Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment , 2013 .

[5]  Nicholas C. Ide,et al.  The Role and Importance of Clinical Trial Registries and Results Databases , 2018 .

[6]  Richard Birtwhistle,et al.  Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. , 2003, BMC medical research methodology.

[7]  V. Lobanov,et al.  Use of ClinicalTrials.gov to estimate condition-specific nocebo effects and other factors affecting outcomes of analgesic trials. , 2013, The journal of pain : official journal of the American Pain Society.

[8]  Karen Chiswell,et al.  The State of Infectious Diseases Clinical Trials: A Systematic Review of ClinicalTrials.gov , 2013, PloS one.

[9]  Christopher W. Jones,et al.  Non-publication of large randomized clinical trials: cross sectional analysis , 2013, BMJ.

[10]  Y. Zhang,et al.  Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population. , 2012, The journal of mental health policy and economics.

[11]  M. Kieny,et al.  Rationale for WHO's New Position Calling for Prompt Reporting and Public Disclosure of Interventional Clinical Trial Results , 2015, PLoS medicine.

[12]  Enrico Coiera,et al.  The automation of systematic reviews , 2013, BMJ.

[13]  F. Collins,et al.  Sharing and reporting the results of clinical trials. , 2015, JAMA.

[14]  Can the pharmaceutical industry embrace comparative effectiveness research? A view from inside , 2013, Expert review of pharmacoeconomics & outcomes research.

[15]  B. Link,et al.  Comparative effectiveness research in follicular lymphoma: current and future perspectives and challenges. , 2014, Journal of comparative effectiveness research.

[16]  James Topping,et al.  Compliance with results reporting at ClinicalTrials.gov. , 2015, The New England journal of medicine.

[17]  S. Greenfield,et al.  Comparative Effectiveness Research: A Report From the Institute of Medicine , 2009, Annals of Internal Medicine.

[18]  Kalpana Raja,et al.  Agile text mining for the 2014 i2b2/UTHealth Cardiac risk factors challenge , 2015, J. Biomed. Informatics.

[19]  C. Clancy,et al.  Comparative-effectiveness research--implications of the Federal Coordinating Council's report. , 2009, The New England journal of medicine.

[20]  Can CER be an effective tool for change in the development and assessment of new drugs and technologies? , 2012, Journal of managed care pharmacy : JMCP.

[21]  J. Newhouse,et al.  Using medicare data for comparative effectiveness research: opportunities and challenges. , 2011, The American journal of managed care.

[22]  L. Hooft,et al.  Identification of Additional Trials in Prospective Trial Registers for Cochrane Systematic Reviews , 2012, PloS one.

[23]  Isabelle Boutron,et al.  Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals , 2013, PLoS medicine.

[24]  S. Ananiadou,et al.  Using text mining for study identification in systematic reviews: a systematic review of current approaches , 2015, Systematic Reviews.

[25]  Nicholas C. Ide,et al.  The ClinicalTrials.gov results database--update and key issues. , 2011, The New England journal of medicine.

[26]  John Hoey,et al.  Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors , 2004, Annals of Internal Medicine.

[27]  Roderik F. Viergever,et al.  The Quality of Registration of Clinical Trials: Still a Problem , 2014, PloS one.

[28]  Despina Koletsi,et al.  Outcome Discrepancies and Selective Reporting: Impacting the Leading Journals? , 2015, PloS one.

[29]  M. Parmar,et al.  More multiarm randomised trials of superiority are needed , 2014, The Lancet.

[30]  Bryan R Luce,et al.  Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change , 2009, Annals of Internal Medicine.

[31]  Shuang Wang,et al.  Assessing the Collective Population Representativeness of Related Type 2 Diabetes Trials by Combining Public Data from ClinicalTrials.gov and NHANES , 2015, MedInfo.

[32]  Clinical Research: A Globalized Network , 2014, PloS one.

[33]  C. Mulrow,et al.  Systematic Reviews: Rationale for systematic reviews , 1994 .

[34]  Sheldon Greenfield,et al.  Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research. , 2012, Journal of comparative effectiveness research.

[35]  H. Krumholz,et al.  Time to publication among completed clinical trials. , 2013, JAMA internal medicine.

[36]  J. Raftery,et al.  The National Institute for Health Research Health Technology Assessment Programme , 2011 .

[37]  Merrick Zwarenstein,et al.  The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research , 2012, Clinical trials.

[38]  C. Tudur Smith,et al.  A comparison of interventional clinical trials in rare versus non-rare diseases: an analysis of ClinicalTrials.gov , 2014, Orphanet Journal of Rare Diseases.

[39]  Manesh R. Patel,et al.  Clinical Trials in Peripheral Vascular Disease: Pipeline and Trial Designs An Evaluation of the ClinicalTrials.gov Database , 2012, Circulation.

[40]  B. Wieseler,et al.  Impact of Inclusion of Industry Trial Results Registries as an Information Source for Systematic Reviews , 2014, PloS one.

[41]  Tianyong Hao,et al.  Clustering clinical trials with similar eligibility criteria features , 2014, J. Biomed. Informatics.

[42]  Steven Duffy,et al.  Searching ClinicalTrials.gov and the International Clinical Trials Registry Platform to inform systematic reviews: what are the optimal search approaches? , 2014, Journal of the Medical Library Association : JMLA.

[43]  K. Mandl,et al.  Comparative Effectiveness Research: An Empirical Study of Trials Registered in ClinicalTrials.gov , 2012, PloS one.

[44]  Alexa T. McCray,et al.  Application of Technology: Design and Implementation of a National Clinical Trials Registry , 2000, J. Am. Medical Informatics Assoc..

[45]  J. Ware,et al.  Randomized clinical trials. Perspectives on some recent ideas. , 1976, The New England journal of medicine.

[46]  Christopher W. Jones,et al.  Clinical trials registries are under-utilized in the conduct of systematic reviews: a cross-sectional analysis , 2014, Systematic Reviews.

[47]  David Ogilvie,et al.  Pinpointing needles in giant haystacks: use of text mining to reduce impractical screening workload in extremely large scoping reviews , 2014, Research synthesis methods.

[48]  Robert M Califf,et al.  Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. , 2012, JAMA.

[49]  Rafael Perera,et al.  New treatments compared to established treatments in randomized trials ( Review ) , 2022 .

[50]  J. Thornton,et al.  Discrepancies between registration and publication of randomised controlled trials: an observational study , 2014, JRSM open.

[51]  Robert F Terry,et al.  Use of data from registered clinical trials to identify gaps in health research and development. , 2013, Bulletin of the World Health Organization.